Loading clinical trials...
Loading clinical trials...
In this Multicenter trial, we will evaluate the feasibility, toxicity, and efficacy of treatment with 90Y Zevalin following a short course of salvage chemotherapy in patients with relapsed/refractory ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
SCRI Development Innovations, LLC
Collaborators
NCT04728893 · Hematologic Malignancies, Waldenstroms Macroglobulinaemia, and more
NCT04496349 · T-Prolymphocytic Leukemia, Non-Hodgkins Lymphoma
NCT00923442 · Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome (MDS), and more
NCT02328014 · Non-Hodgkins Lymphoma, Multiple Myeloma, and more
NCT04188678 · Leukemia, Lymphoma, and more
Tennessee Oncology, PLLC
Nashville, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions